4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bal Pharma Limited (BALPHARMA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Bengaluru, India with about 939 employees. Its market capitalization is roughly ₹2 billion. In the fiscal year ended 2026-03-31, BALPHARMA reported ₹3.0B in revenue and ₹63M in net income.
Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹3.0B | ₹2.9B | ₹3.3B | ₹3.0B | — |
| Gross Profit | ₹1.4B | ₹1.3B | ₹1.3B | ₹1.3B | — |
| Operating Income (EBIT) | ₹229M | ₹201M | ₹218M | ₹175M | — |
| Net Income | ₹63M | ₹72M | ₹74M | ₹26M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹886M | ₹841M | ₹877M | ₹740M | ₹659M | — |
| Gross Profit | ₹375M | ₹458M | ₹415M | ₹341M | ₹323M | — |
| Operating Income (EBIT) | ₹52M | ₹75M | ₹63M | ₹35M | ₹35M | — |
| Net Income | ₹11M | ₹36M | ₹18M | ₹7M | ₹2M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹19M) | (₹19M) | (₹16M) | (₹16M) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹3.8B | ₹3.4B | ₹3.2B | ₹3.1B | — |
| Total Liabilities | ₹2.9B | ₹2.6B | ₹2.5B | ₹2.5B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BALPHARMA viewer.
About TickerBase · Data methodology & sources · Privacy · Terms